CIK 0001936258 · Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- 4 Planned sale Chief Operating Officer sold 100,000 shares
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 69 shares (option exercise)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Option exercise Director acquired 69 shares (option exercise)
- 4 Planned sale Chief Operating Officer sold 100,000 shares
- 4 Grant or award Director acquired 10,860 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 1,135 shares at $22.49 ($25,521)
- 4 Option exercise Chief Accounting Officer acquired 8,269 shares (option exercise)
Page 7 of 21 · 415 filings